Sekine, Masayuki http://orcid.org/0000-0003-0751-6395
Enomoto, Takayuki
Watanabe, Yoh
Katabuchi, Hidetaka
Yaegashi, Nobuo
Aoki, Daisuke
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 16 March 2021
Accepted: 19 July 2021
First Online: 26 July 2021
Change Date: 9 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10147-021-02018-3
Declarations
:
: Masayuki Sekine has received honoraria from AstraZeneca K.K. Takayuki Enomoto has received honoraria from AstraZeneca K.K. and Chugai Pharmaceutical Co., Ltd. Daisuke Aoki has received honoraria from Chugai Pharmaceutical Co., Ltd. Yoh Watanabe, Hidetaka Katabuchi, and Nobuo Yaegashi have no conflict of interest. The authors confirm that they have full control of all primary data, and they agree to allow the journal to review their data if requested.
: This study was approved by the Ethics Committee of the primary study facility (Niigata University, Niigata, Japan) and the Ethics Committees of all other participating facilities.